rac A77 1726 is the active metabolite of Leflunomide, a potent disease-modifying antirheumatic drug used in the treatment of rheumatoid arthritis. LEF-M interferes with dendritic cell function. The second Phase III study evaluating the efficacy of Genzymes teriflunomide therapy against relapsing forms of multiple sclerosis found the once-daily oral drug to be no less effective than injectable interferon beta 1a (Rebif). Leflunomide USP Related Compound B. Molecular Formula: C12H9F3N2O2 Solubility: DMSO (Slightly), Methanol (Sparingly) Molecular Weight: 270.20999999999998 Storage and Stability: Store at -20C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Molecular Weight:
270.21
Form:
Supplied as a White Solid
CAS Number:
[108605-62-5]
* VAT and and shipping costs not included. Errors and price changes excepted
